Neurotech Progress Stifled by Transhumanist Hype, Experts Warn
A breakthrough year for neurotechnology has been overshadowed by the ambitions of its most prominent investors. The prospect of uploading human brains into computers or merging with artificial intelligence has sparked concerns among experts, who argue that it is "dumb transhumanist ideas" distorting the debate and stifling progress in the field.
While companies like Neuralink and Merge Labs are working on developing innovative brain-computer interfaces, their CEOs, Elon Musk and Sam Altman, have been vocal about their own ambitions for a future where humans can upload their memories into a new body or robot. These ideas, experts say, are "completely unrealistic" and are hiding the real questions being asked in neurotechnology.
Marcello Ienca, a professor of neuroethics at the Technical University of Munich, notes that these narratives are "distorting the debate a lot." He argues that rich investors with no medical background are muddying public understanding of the potential of neurotechnology and creating unrealistic expectations about what can be achieved.
Michael Hendricks, a professor of neurobiology at McGill, is equally skeptical. "Rich people who are fascinated with these dumb transhumanist ideas" are confusing the field, he says. "Neuralink is doing legitimate technology development for neuroscience, but Elon Musk comes along and starts talking about telepathy and stuff."
As investors pour more money into neurotechnologies, experts warn that the industry's focus on consumer wearables and science fiction applications is diverting attention away from more pressing medical needs.
"The evidential robustness of these systems is very limited," says Ienca. "There are very few replicable studies." Hendricks agrees, stating that devices like EEG earphones are unlikely to be effective surveillance tools because the data is too noisy and unreliable in individual cases.
However, neuroscientist HervΓ© Chneiweiss raises concerns about the potential for these technologies to be used as a means of surveillance. "If they are used in the workplace, they could monitor your brain fatigue or things like that," he says. "The data could be used to discriminate."
As the field of neurotechnology continues to evolve, experts urge caution and emphasize the need for more scientific rigor and responsible investment practices.
"We have so many ways to influence people through language and simple visual media," Hendricks says. "I don't think [brain implants] would catch up for a long time."
A breakthrough year for neurotechnology has been overshadowed by the ambitions of its most prominent investors. The prospect of uploading human brains into computers or merging with artificial intelligence has sparked concerns among experts, who argue that it is "dumb transhumanist ideas" distorting the debate and stifling progress in the field.
While companies like Neuralink and Merge Labs are working on developing innovative brain-computer interfaces, their CEOs, Elon Musk and Sam Altman, have been vocal about their own ambitions for a future where humans can upload their memories into a new body or robot. These ideas, experts say, are "completely unrealistic" and are hiding the real questions being asked in neurotechnology.
Marcello Ienca, a professor of neuroethics at the Technical University of Munich, notes that these narratives are "distorting the debate a lot." He argues that rich investors with no medical background are muddying public understanding of the potential of neurotechnology and creating unrealistic expectations about what can be achieved.
Michael Hendricks, a professor of neurobiology at McGill, is equally skeptical. "Rich people who are fascinated with these dumb transhumanist ideas" are confusing the field, he says. "Neuralink is doing legitimate technology development for neuroscience, but Elon Musk comes along and starts talking about telepathy and stuff."
As investors pour more money into neurotechnologies, experts warn that the industry's focus on consumer wearables and science fiction applications is diverting attention away from more pressing medical needs.
"The evidential robustness of these systems is very limited," says Ienca. "There are very few replicable studies." Hendricks agrees, stating that devices like EEG earphones are unlikely to be effective surveillance tools because the data is too noisy and unreliable in individual cases.
However, neuroscientist HervΓ© Chneiweiss raises concerns about the potential for these technologies to be used as a means of surveillance. "If they are used in the workplace, they could monitor your brain fatigue or things like that," he says. "The data could be used to discriminate."
As the field of neurotechnology continues to evolve, experts urge caution and emphasize the need for more scientific rigor and responsible investment practices.
"We have so many ways to influence people through language and simple visual media," Hendricks says. "I don't think [brain implants] would catch up for a long time."